BiotechTube
Home/Meiji Seika Pharma/Daikichiro Kobayashi
DK

Daikichiro Kobayashi

President and Representative Director

Meiji Seika Pharma

Therapeutic Areas

Infectious DiseaseOncology

Meiji Seika Pharma Pipeline

DrugIndicationPhase
ME1100 (arbekacin inhalation solution)Pulmonary infections caused by multidrug-resistant pathogensPhase 3
CefiderocolInfections caused by multidrug-resistant Gram-negative bacteriaApproved
Various oncology candidatesMultiple cancer typesVarious

Leadership Team at Meiji Seika Pharma

YK
Yoshihiko Kawasaki
Senior Managing Executive Officer, Head of R&D
View full Meiji Seika Pharma profile